Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic

Novo Nordisk's forecast only confirms the frenzy for Wegovy and Ozempic, which patients seek for their ability to help them lose significant weight over time.

from Health and Science https://ift.tt/pbem1ch
https://ift.tt/xaImUjt
https://ift.tt/RqEbSX4